Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Adamas Pharma
(NQ:
ADMS
)
4.890
USD
-0.240 (-4.68%)
Streaming Delayed Price
Updated: 11:36 AM EST, Mar 4, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Adamas Pharma
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Adamas Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 01, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced...
From
Business Wire News Releases
Adamas Pharmaceuticals Announces Pricing of Follow-on Public Offering
February 24, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced...
From
Business Wire News Releases
Adamas Pharmaceuticals Announces Launch of Follow-on Public Offering
February 24, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced...
From
Business Wire News Releases
Adamas Reports Fourth Quarter and Full Year 2020 Financial Results
February 23, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today reported...
From
Business Wire News Releases
Adamas to Present at Upcoming Healthcare Conferences
February 17, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced...
From
Business Wire News Releases
Adamas to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call on February 23, 2021
February 10, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report fourth quarter and year-end 2020 financial results on Tuesday, February 23, 2021, after market close....
From
Business Wire News Releases
Adamas Announces FDA Approval for Second Indication for GOCOVRI® as an Adjunctive Treatment to levodopa/carbidopa in Parkinson’s Disease Patients Experiencing OFF Episodes
February 01, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it...
From
Business Wire News Releases
Adamas Announces Settlement of Patent Litigation with Zydus
February 01, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a clinically meaningful difference to people affected by neurological diseases, today...
From
Business Wire News Releases
Adamas Provides Preliminary Fourth Quarter and Full Year 2020 Total Revenues and Key Business Drivers for 2021
January 13, 2021
From
GlobeNewswire News Releases
Adamas to Present at Upcoming ICR Conference
January 07, 2021
From
GlobeNewswire News Releases
Adamas Completes Acquisition of OSMOLEX ER®
January 05, 2021
Royalty-Backed Loan Agreement Amendment Effective with OSMOLEX ER Acquisition
From
GlobeNewswire News Releases
Adamas to Present at Upcoming H.C. Wainwright Conference
January 04, 2021
From
GlobeNewswire News Releases
Adamas Announces New Employment Inducement Grant
December 11, 2020
From
GlobeNewswire News Releases
Adamas Announces Agreement to Amend Royalty-Backed Loan Agreement with HealthCare Royalty Partners
December 02, 2020
Amended terms will provide added flexibility to help drive the growth of the Company
From
GlobeNewswire News Releases
Adamas Announces Agreement to Settle Patent Litigation with Osmotica
December 02, 2020
As part of this agreement Adamas will acquire the global rights to OSMOLEX ER®
From
GlobeNewswire News Releases
Adamas to Present at Upcoming Evercore ISI Conference
November 24, 2020
From
GlobeNewswire News Releases
Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg
November 23, 2020
From
GlobeNewswire News Releases
Adamas to Present at Upcoming Piper Sandler Conference
November 18, 2020
From
GlobeNewswire News Releases
Adamas Announces New Employment Inducement Grant
November 13, 2020
From
GlobeNewswire News Releases
Adamas Reports Third Quarter 2020 Financial Results
November 05, 2020
From
GlobeNewswire News Releases
Adamas announces settlement agreement of previously disclosed class action litigation
November 02, 2020
From
GlobeNewswire News Releases
Adamas to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 5, 2020
October 26, 2020
From
GlobeNewswire News Releases
Adamas Announces New Employment Inducement Grant
October 09, 2020
From
GlobeNewswire News Releases
Adamas appoints new Chief Medical Officer, Adrian Quartel, MD
October 01, 2020
From
GlobeNewswire News Releases
Adamas Announces New Employment Inducement Grant
September 11, 2020
From
GlobeNewswire News Releases
Adamas presents new post-hoc data analysis for GOCOVRI® in Parkinson’s disease patients with dyskinesia at the 2020 Movement Disorder Society Virtual Congress
September 11, 2020
From
GlobeNewswire News Releases
Adamas to Present at Upcoming HC Wainwright Conference
September 08, 2020
From
GlobeNewswire News Releases
Adamas Appoints Anna Richo to Board of Directors
September 01, 2020
From
GlobeNewswire News Releases
Adamas Announces New Employment Inducement Grant
August 14, 2020
From
GlobeNewswire News Releases
Stocks That Surged Higher Over The Past Week: $ZSAN $ADMS $EXPI
August 10, 2020
Tags
The Market Signal
From
The Market Signal
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.